I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 48 050 VND -0.93%
Market Cap: 7.4T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Imexpharm Corp
Gain/Loss on Disposition of Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Imexpharm Corp
Gain/Loss on Disposition of Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gain/Loss on Disposition of Assets CAGR 3Y CAGR 5Y CAGR 10Y
I
Imexpharm Corp
VN:IMP
Gain/Loss on Disposition of Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
HaTay Pharmaceutical JSC
VN:DHT
Gain/Loss on Disposition of Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cuu Long Pharmaceutical JSC
VN:DCL
Gain/Loss on Disposition of Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Gain/Loss on Disposition of Assets
â‚«227.9m
CAGR 3-Years
N/A
CAGR 5-Years
-34%
CAGR 10-Years
N/A
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Gain/Loss on Disposition of Assets
â‚«1.7B
CAGR 3-Years
64%
CAGR 5-Years
-26%
CAGR 10-Years
-37%
T
Traphaco JSC
VN:TRA
Gain/Loss on Disposition of Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Imexpharm Corp
Glance View

Market Cap
7.4T VND
Industry
Pharmaceuticals

Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

IMP Intrinsic Value
27 228.06 VND
Overvaluation 43%
Intrinsic Value
Price
I

See Also

Back to Top